SCHEMBL7950813

SCHEMBL7950813

CC(C)=CC(=O)N1CC(NC(=O)OC(C)(C)C)C(=O)Nc2cc(C)ccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.37
EPHX2 P34913 1/20 0.36
PIM1 P11309 1/20 0.34
PIM3 Q86V86 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
NFKB1 P19838 2/20 0.32
NFKB2 Q00653 2/20 0.32
RELA Q04206 2/20 0.32
CYP1A2 P05177 1/20 0.32
POLB P06746 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
HSD17B10 Q99714 2/20 0.32
ALOX15 P16050 1/20 0.32
USP2 O75604 2/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7950687 0.89 GAA (0.40) GAAEPHX2PIM1PIM3PIM2
SCHEMBL6176303 0.86 GAA (0.40) GAAEPHX2PIM1PIM3PIM2
SCHEMBL6177881 0.84 GAA (0.38) GAAEPHX2PIM1PIM3PIM2
SCHEMBL7950643 0.84 GAA (0.38) GAAEPHX2PIM1PIM3PIM2
SCHEMBL6179125 0.84 EPHX2 (0.39) GAAEPHX2PIM1PIM3PIM2
SCHEMBL6176414 0.83 EPHX2 (0.41) GAAEPHX2PIM1PIM3PIM2
SCHEMBL7960759 0.83 GAA (0.37) GAAEPHX2PIM1PIM3PIM2
SCHEMBL7958883 0.82 GAA (0.36) GAAEPHX2PIM1PIM3PIM2
SCHEMBL7950898 0.80 HTT (0.43) GAAEPHX2POLBHSD17B10KDM4E
SCHEMBL7959374 0.80 ALDH1A1 (0.43) GAAEPHX2PIM1PIM3PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed